Generic name: NORGESTIMATE 0.18mg, ETHINYL ESTRADIOL 0.035mg; NORGESTIMATE 0.215mg, ETHINYL ESTRADIOL 0.035mg; NORGESTIMATE 0.25mg, ETHINYL ESTRADIOL 0.035mg;
Dosage form: tablets
- Tri-Estarylla tablets
- Tri-Lo-Estarylla tablets
- Tri-Lo-Marzia tablets
- Tri-Lo-Mili tablets
- Tri-Lo-Sprintec tablets
- Tri-Mili tablets
- Tri-Previfem tablets
- Tri-Sprintec tablets
- TriNessa tablets
- TriNessa Lo tablets
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
How to Start Tri-Linyah
Tri-Linyah is dispensed in 28-tablet blister [see How Supplied/Storage and Handling (16)]. Tri-Linyah may be started using either a Day 1 start or a Sunday start (see Table 1). The plastic compact is pre-set for a Sunday start. Day 1 Start day-label stickers are available. For the first cycle of a Sunday Start regimen, an additional method of contraception should be used until after the first 7 consecutive days of administration.
How to Take Tri-Linyah
● After a first-trimester abortion or miscarriage, Tri-Linyah may be started immediately. An additional method of contraception is not needed if Tri-Linyah is started immediately.
● If Tri-Linyah is not started within 5 days after termination of the pregnancy, the patient should use additional non-hormonal contraception (such as condoms and spermicide) for the first seven days of her first cycle pack of Tri-Linyah.
● Do not start until 4 weeks after a second-trimester abortion or miscarriage, due to the increased risk of thromboembolic disease. Start Tri-Linyah, following the instructions in Table 1 for Day 1 or Sunday start, as desired. If using Sunday start, use additional non-hormonal contraception (such as condoms and spermicide) for the first seven days of the patient's first cycle pack of Tri-Linyah. [See Contraindications (4), Warnings and Precautions (5.1), and FDA-Approved Patient Labeling.]
Starting Tri-Linyah after Childbirth
● Do not start until 4 weeks after delivery, due to the increased risk of thromboembolic disease. Start contraceptive therapy with Tri-Linyah following the instructions in Table 1 for women not currently using hormonal contraception.
● Tri-Linyah is not recommended for use in lactating women [see Use in Specific Populations (8.3)].
● If the woman has not yet had a period postpartum, consider the possibility of ovulation and conception occurring prior to use of Tri-Linyah. [See Contraindications (4), Warnings and Precautions (5.1), Use in Specific Populations(8.1 and 8.3), and FDA-Approved Patient Labeling].
Compact Blister Dispenser
If the patient starts pill-taking on Sunday, the first active pill should be taken on the first Sunday after the patient's menstrual period begins. Remove the first active pill at the top of the dispenser (Sunday) by pressing the pill through the blister foil.
If the pa tient will start pill-taking on "Day 1," place a day-label sticker on the compact which starts with the day of the week the patient will take the first pill. Remove the first active pill a t the top of the dispenser (Day 1) by pressing the pill through the blister foil.
Advice in Case of Gastrointestinal Disturbances
In case of severe vomiting or diarrhea, absorption may not be complete and additional contraceptive measures should be taken. If vomiting or diarrhea occurs within 3 to 4 hours after taking an active tablet, handle this as a missed tablet [see FDA-Approved Patient Labeling].
Tri-Linyah Use for Acne
The timing of initiation of dosing with Tri-Linyah for acne should follow the guidelines for use of Tri-Linyah as an oral contraceptive. Consult the DOSAGE AND ADMINISTRATION section (2.1) for instructions.